Tag: TRXC

Blue Horseshoe Stocks: BLNK, Bottom-Play & More

Blink Charging Co. BLNK

We signaled our interest in BLNK in yesterday morning’s premarket report via the Extended Watchlist, and we’re happy to report on what was a very productive first day of observation.

From a low of 4.34, BLNK made a highly respectable intraday run to 6.34, marking an intraday push of 46% Prior to Monday’s session, wherein the stock picked up in a big way, it had been trading sideways for quite some time. We will be interested in monitoring this play for the possibility of a more sustained uptrend in the days ahead.

Gogo. Inc. GOGO

We want to also bring some attention to the massive selloff which has occurred over the past three trading days. After trading for nearly $10/share, a disappointing earnings release and subsequent Moody’s downgrade has precipitated close to a 50% drop, leaving GOGO trading at just above $5.

We’re going to want to put this one on intensive bottom-watch, as we prepare for possible course correction leading to a bounce play opportunity.

Fresh Options Idea:
Trip Advisor, Inc. TRIP Weekly $45.50 & $46 Calls

Extended Watchlist:
UURAF, TRXC, PLUG, LC, MNKD, GRPN, ICHR, TWLO

Blue Horseshoe Stocks: Winning Options Trades & More

More Winning Options Trades

We submitted a pair of daytrading ideas for the NVDA and ROKU options chains, and it’s no surprise that both ideas turned out to be winners for us. Our lack of shock stems from the fact that we have been absolutely crushing it when it comes to options. We always have solid success in this arena, but the past few weeks have been more loaded with huge gainers for us more than even we are accustomed to, and Friday continued that trend convincingly.

We had the NVIDIA Corp. – NVDA Weekly $205-212.50 Calls as well as the Roku, Inc. – ROKU Weekly $28-30 Calls on watch for the day, and there wasn’t a single contract contained within either of those ranges that didn’t provide us with some really nice chances for big gains. Those were as follows:

NVDA Weekly $205-212.50 Calls
$205 Calls – Range: 7.50-13.59 – Max Gain: 81%
$207.50 Calls – Range: 5.55-11.06 – Max Gain: 99%
$210 Calls – Range: 3.65-8.60 – Max Gain: 136%
$212.50 Calls – Range: 1.90-7.22 – Max Gain: 280%

ROKU Weekly $28-30 Calls
$28 Calls – Range: 2.60-8.00 – Max Gain: 207%
$29 Calls – Range: 1.90-7.22 – Max Gain: 280%
$30 Calls – Range: 1.10-6.50 – Max Gain: 491%

JB&ZJMY Holding Company, Inc. JBZY

We also want to make note of JBZY, which has a pretty good chart setup at the moment. The stock was trending up off of its 50DMA throughout last week, and is sitting at .08 currently.

With a recent run to .16 showing us what this play is capable of in just a short time, we’ll go ahead and put it on watch as we start off a new trading week. As we’ve pointed out on the snapshot below, another bullish cross looks inevitable for the MACD.

Extended Watchlist:
TRXC, GV, RLOG, BIOA, NQ, PRTY, CEI

Blue Horseshoe Stocks: TRXC Recap, Bottom Play & More

 TransEnterix, Inc. TRXC

We caught TRXC for a pretty nice move earlier this month, when we alerted it on the 16th, and the stock went on a two-day run from 2.15 to 4.43, scoring us a solid double-bagger.

In the weeks since then, TRXC has been under consolidation, and yesterday, we tagged it once again in our extended watchlist, and the stock produced what may be the start of another solid uptrend.

From a low of 2.50, the stock went as high as 3.03, making for a 21% rise on the day, and it maintained more than half of that move into the close on better-than-average volume.

We’ll continue to monitor for the establishment of higher highs and higher lows as TRXC attempts to get its next leg-up.

Immune Design Corp. IMDZ

We’ve got an interesting bottom setup on IMDZ, which recently took a massive downturn following the announcement of a large $80M public offering at a price of 4.10/share.

It’s also important to note that there was a huge $10M block of insider buying that came in on Friday near the lows.

Additionally, as you can see on the chart, the result of the last week of activity is a highly oversold state, and all indications seems to be pointing to the possibility of the stock regaining at least a portion of the ground it has recently lost.

Lastly, the company will be a hosting a post-market conference call tomorrow to discuss 3Q earnings and recent developments that you can tune into at http://ir.immunedesign.com/events.cfm after market close tomorrow and for 30 days thereafter.

As an added idea, we’ll radar the IMDZ 12/15 $5 Calls for observation in the days and weeks ahead. Those could see some nice activity if the stock has the recovery we suspect it might.

Extended Watchlist:
APTI, IDTI, IDRA, CGNX, MDLZ, SNE, NVAX, AMD(Bottom-Watch)